首页 | 本学科首页   官方微博 | 高级检索  
     

氧代赖氨酸与5—FU联合治疗肿瘤的实验研究
引用本文:乐秀芳 吴富根. 氧代赖氨酸与5—FU联合治疗肿瘤的实验研究[J]. 中国医药工业杂志, 1989, 20(8): 360-362
作者姓名:乐秀芳 吴富根
作者单位:中国科学院上海药物研究所,中国科学院上海药物研究所,中国科学院上海药物研究所 上海 200031,上海 200031,上海 200031
基金项目:中国科学院科学基金资助课题
摘    要:氧代赖氨酸(I-677)的抗肿瘤作用是由于影响蛋白质的生物合成,本文将它与一些已知的影响核酸代谢的抗肿瘤药物用于联合治疗。发现与5-FU合用时能提高疗效。单用氧代赖氨酸(400mg/kg)ip 2次,或5-FU(25m/kg)ip 3次,对肉瘤37无抑制作用,合用时则产生显著的抑制效果。

关 键 词:氧代赖氨酸 5-氟脲嘧啶 肿瘤

COMBINATION CHEMOTHERAPY TRIALS OF OXALYSINE WITH 5-FU IN EXPERIMENTAL ANIMAL TUMOR
YUE Xiu-Fang,WU Fu-Geng,XU Bin. COMBINATION CHEMOTHERAPY TRIALS OF OXALYSINE WITH 5-FU IN EXPERIMENTAL ANIMAL TUMOR[J]. , 1989, 20(8): 360-362
Authors:YUE Xiu-Fang  WU Fu-Geng  XU Bin
Abstract:Oxalysine reduced the content of fibrinogen in mice bearing solidtumor and inhibited the synthesis of histone in tumor cells. The effect of com-bination chemotherapy of oxalysine with other antitumor drugs, which inhibitedthe synthesis of nucleic acid, was studied. The results showed that treatment of mice bearing sarcoma 37 with oxaly-sine (400 mg/kg on days 1, 4) or 5-FU (25mg/kg on days 2, 5, 7) alone pro-duced only 10% and 27% inhibitory rate, respectively. Combination chemotherapywith the same treatment schedule increased the inhibitory rate to 43%.Suchresults might be meaningful for clinical trials.
Keywords:oxalysine   5-FU   combination chemotherapy   sarcoma 37
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号